Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Intervalo de año de publicación
1.
Oncogene ; 36(44): 6154-6163, 2017 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-28692051

RESUMEN

Sun-induced skin lesions, in particular actinic keratosis, are generally considered as premalignant skin lesions that can progress into squamous cell carcinoma (SCC) and invasive SCC if left untreated. Therefore, understanding the molecular mechanisms by which the ultraviolet-B (UV-B)-exposed cells are being protected and the signaling pathways that promote the progression of certain premalignant skin lesions to malignant lesions will permit us to prevent or cure skin cancers. In the current study, we found that phospho-p21-activated kinase-1 (Pak1) and Pak1 expression was high in clinical samples of sunlight-induced premalignant skin lesions assessed by immunohistochemistry. Further, we observed that phospho-Pak1 and Pak1 levels are high in UV-B-exposed hairless SKH mouse model skin samples as compared with unexposed skin tissue. Our results from cell line and animal models showed that Pak1 is activated in response to UV-B radiation, and this activated Pak1 translocates from the cytoplasm to the nucleus. Inside the nucleus, Pak1 via C-Fos binds to a specific promoter region of DNA repair kinase ATR (ataxia-telangiectasia and Rad3-related protein) and acts as a transcriptional regulator of ATR. Results from our analysis showed that Pak1 overexpression, knockdown and Pak1 knockout cell line models showed that Pak1 confers protection to keratinocytes from UV-B-induced apoptosis and DNA damage via ATR. To our knowledge, this is the first study that evaluates the functional and clinical significance of a signaling molecule, Pak1, in sun-induced premalignant skin lesions and indicates that increased Pak1 activation and expression could serve as an early warning sign of progression toward non-melanoma skin cancer, if ignored.


Asunto(s)
Carcinoma de Células Escamosas/genética , Neoplasias Inducidas por Radiación/genética , Neoplasias Cutáneas/genética , Quinasas p21 Activadas/genética , Animales , Apoptosis/efectos de la radiación , Proteínas de la Ataxia Telangiectasia Mutada/genética , Carcinoma de Células Escamosas/patología , Línea Celular Tumoral , Daño del ADN/efectos de la radiación , Modelos Animales de Enfermedad , Regulación Neoplásica de la Expresión Génica/efectos de la radiación , Humanos , Queratinocitos/metabolismo , Queratinocitos/patología , Queratinocitos/efectos de la radiación , Ratones , Neoplasias Inducidas por Radiación/patología , Lesiones Precancerosas/genética , Lesiones Precancerosas/patología , Piel/metabolismo , Piel/patología , Piel/efectos de la radiación , Neoplasias Cutáneas/patología , Luz Solar/efectos adversos , Rayos Ultravioleta/efectos adversos
2.
Artículo en Inglés | LILACS | ID: lil-582934

RESUMEN

The lip vermillion constitutes a transition tissue, between oral mucosa and skin, where oral mucosal cells from epithelial and connective tissue compartments are exposed to ultraviolet (UV) sunlight. Fibroblasts are abundant resident cells of the connective tissue which are key regulators of extracellular matrix composition, as well as, epithelial and endothelial cell function. UVB light, an inherent component of sunlight, causes several alterations in skin fibroblasts, including premature senescence and increased cyclooxygenase (COX)-2 expression. To assess if UVB irradiation had similar effects on fibroblasts derived from human oral mucosa (HOM), primary cultures of HOM fibroblasts were irradiated with a single dose of 30 or 60 mJ/cm²of UVB light or sham-irradiated. Fibroblast proliferation was assessed from 3 to 48 hrs after UVB-irradiation utilizing [³H]-thymidine incorporation and MTT assays. In addition, COX-2 mRNA expression was detected by RT-PCR, and PGE2 production was assessed using enzyme immunoassay from 0.5 to 24 hrs after UVB-irradiation. The results showed a significant decrease in proliferation of UVB-irradiated HOM fibroblasts as compared to controls as measured by both [³H]-thymidine incorporation and MTT assays (p<0.001). HOM fibroblasts had increased COX-2 mRNA expression at 0.5 and 12 hrs after irradiation, and PGE2 production was elevated at 12 and 24 hrs post-irradiation as compared to controls (p<0.05). The results showed an inhibitory effect of a single dose of UVB irradiation on HOM fibroblast proliferation with an increase in COX-2 expression and activation. Therefore, photodamaged fibroblasts may play and important role in the pathogenesis of UV-induced lesions of the lip.


Asunto(s)
Humanos , /efectos de la radiación , Fibroblastos/efectos de la radiación , Mucosa Bucal/citología , Rayos Ultravioleta , Fibroblastos/enzimología , Mucosa Bucal/efectos de la radiación , Mucosa Bucal/enzimología , Proliferación Celular , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
4.
Adv Exp Med Biol ; 507: 85-92, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12664569

RESUMEN

Ultraviolet B (UVB) radiation is responsible for the majority of cutaneous damage following both acute and long-term exposure, and is believed to be the most important etiologic agent in human skin cancer. UVB carcinogenesis initially induces an inflammatory response characterized by edema, dermal infiltration of leukocytes, as well as the production and release of prostaglandins, which may be critical to the observed damaging effects of UVB light on skin. Recently, a specific cyclooxygenase-2 (COX-2) inhibitor, Celecoxib, was developed, which inhibits COX-2-induced inflammation without inhibiting the cytoprotective function of cyclooxygenase-1 (COX-1). Studies have demonstrated that oral administration of Celecoxib decreased the incidence of skin and colon tumors. Recently, the process of inflammation has been linked to tumor formation. The present study examined the effects of a topical application of Celecoxib on the acute UVB-induced cutaneous inflammatory response. We show that topical Celecoxib treatment effectively reduced many parameters of UVB-mediated inflammation, including edema, dermal myeloperoxidase activity, neutrophil infiltration, and prostaglandin E2 (PGE2) levels. By inhibiting this inflammatory response, topical Celecoxib treatment could ultimately be effective in preventing tumor development and progression in the skin, which is known to result from long-term UV exposure.


Asunto(s)
Inhibidores de la Ciclooxigenasa/uso terapéutico , Inflamación/prevención & control , Isoenzimas/genética , Prostaglandina-Endoperóxido Sintasas/genética , Traumatismos por Radiación/prevención & control , Enfermedades de la Piel/prevención & control , Rayos Ultravioleta/efectos adversos , Animales , Biomarcadores , Ciclooxigenasa 2 , Inhibidores de la Ciclooxigenasa 2 , Cartilla de ADN , Femenino , Hipoxantina Fosforribosiltransferasa/genética , Inflamación/etiología , Isoenzimas/metabolismo , Ratones , Ratones Pelados , Neutrófilos/efectos de los fármacos , Neutrófilos/enzimología , Neutrófilos/fisiología , Peroxidasa/metabolismo , Prostaglandina-Endoperóxido Sintasas/metabolismo , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Enfermedades de la Piel/etiología
5.
Arch Phys Med Rehabil ; 82(9): 1279-82, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11552204

RESUMEN

OBJECTIVE: To evaluate the efficacy of carbidopa L-dopa (Sinemet) in reducing left spatial neglect after stroke. DESIGN: Case series. SETTING: Inpatient neurorehabilitation unit in a regional rehabilitation center. PARTICIPANTS: A convenience sample of 4 women with right brain strokes and left neglect. INTERVENTION: A trial of carbidopa L-dopa to treat left neglect, if indicated by selected subtests of the Behavioral Inattention Test (BIT). MAIN OUTCOME MEASURES: Baseline and posttreatment evaluation with the modified BIT and the FIM instrument. RESULTS: Three of 4 subjects had significant improvements in their modified BIT scores (8%, 12%, 27%, respectively) and their functional status on the FIM. CONCLUSION: With further study, carbidopa L-dopa may be shown to reduce unilateral spatial neglect and thereby improve rehabilitation outcomes.


Asunto(s)
Carbidopa/uso terapéutico , Dopaminérgicos/uso terapéutico , Levodopa/uso terapéutico , Trastornos de la Percepción/tratamiento farmacológico , Trastornos de la Percepción/etiología , Accidente Cerebrovascular/complicaciones , Actividades Cotidianas , Anciano , Carbidopa/metabolismo , Carbidopa/farmacología , Dopaminérgicos/metabolismo , Dopaminérgicos/farmacología , Femenino , Evaluación Geriátrica , Humanos , Levodopa/metabolismo , Levodopa/farmacología , Trastornos de la Percepción/clasificación , Trastornos de la Percepción/diagnóstico , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
6.
Photochem Photobiol ; 73(2): 184-90, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11272733

RESUMEN

Peptides derived from the heavy chain of the HLA Class-I molecules have been shown to modulate immune responses both in vivo and in vitro. Using a computer-aided rational drug design approach, novel immunomodulatory peptides were designed based on peptide 2702.75-85, derived from HLA-B2702. Several peptides were identified which had increased immunomodulatory activity, including peptides RDP1258 and its D-isomer the peptide Allotrap 1258. The present study using Skh/hr hairless mouse skin model evaluated the in vivo effects of Allotrap 1258 on acute UVB-induced skin inflammation. Here we demonstrate that intraperitoneal administration of Allotrap 1258 1 h prior to UV exposure resulted in significantly diminished levels of UV-induced tumor necrosis factor (TNF)-alpha protein production in the epidermis but had no effect on other parameters of the acute UV-induced inflammatory response. By virtue of its ability to suppress TNF-alpha protein production, Allotrap 1258 could prove to be an effective modulator of inflammatory responses.


Asunto(s)
Piel/efectos de la radiación , Factor de Necrosis Tumoral alfa/biosíntesis , Adyuvantes Inmunológicos/farmacología , Animales , Femenino , Inmunohistoquímica , Ratones , Ratones Pelados , Péptidos/farmacología , Piel/inmunología , Piel/patología , Factor de Necrosis Tumoral alfa/genética , Rayos Ultravioleta/efectos adversos
7.
Biochem Biophys Res Commun ; 247(3): 644-53, 1998 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-9647747

RESUMEN

One of the most frequently detected changes in human solid tumors is the mutation of the ras oncogene, which has been associated with production of angiogenic growth factors such as vascular endothelial growth factor/vascular permeability factor (VEGF/VPF). Using the v-Ha-ras Tg-AC transgenic mice and the background FVB/N strain of inbred mice, the pattern of expression of specific VEGF/VPF transcripts was characterized in major organs and in skin, papillomas, and carcinomas during multi-stage skin carcinogenesis. Three VEGF/VPF transcripts were found to be constitutively expressed in skin as well as the major organs in both mouse strains, which corresponded in size and sequence to previously reported murine VEGF120 with a bp size of 331, VEGF164 with a bp size of 333, and VEGF188 with a bp size of 407. A previously unreported fourth murine transcript was also detected in skin and major tissues from both mouse strains which corresponded to rat VEGF144, with a bp size of 404. In addition, a unique 425 bp VEGF transcript which corresponded to human VEGF205 was present in highly vascularized tissues including heart, lung, liver, kidney, brain, as well in papillomas and carcinomas isolated from v-Ha-ras Tg.AC mice. In contrast, VEGF205 was present only in carcinomas derived from FVB/N mice. An antibody generated from a peptide sequence designed to detect each of the five VEGF/VPF peptides defined by RT-PCR analysis confirmed the existence of these five peptides and confirmed that the murine VEGF205 peptide was selectively expressed in papillomas and carcinomas derived from v-Ha-ras Tg.AC mice. These results demonstrate that there is significant alternative splicing of the murine VEGF/VPF gene during multi-stage carcinogenesis, which results in four commonly expressed VEGF transcripts. In addition, these studies identified a fifth VEGF transcript and peptide at the later stages of tumor promotion and in progression which appears to be linked to the presence of v-Ha-ras.


Asunto(s)
Factores de Crecimiento Endotelial/genética , Regulación Neoplásica de la Expresión Génica/genética , Genes ras/genética , Linfocinas/genética , Neoplasias Cutáneas/genética , Empalme Alternativo/genética , Animales , Ratones , Ratones Endogámicos , Ratones Transgénicos , Proteínas de Neoplasias/química , Neovascularización Patológica/fisiopatología , Papiloma/genética , Reacción en Cadena de la Polimerasa , ARN Mensajero/genética , Neoplasias Cutáneas/patología , Transcripción Genética/genética , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial Vascular
8.
Mol Carcinog ; 22(1): 16-25, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9609097

RESUMEN

It is now recognized that ultraviolet (UV) radiation is a potent environmental insult capable of interfering with immunity to skin cancers and modifying certain immunologic reactions within both locally irradiated skin and distant, unexposed sites. Exposure to UVB light (290-320 nm) induces a potent cutaneous inflammatory response that involves the infiltration of leukocytes into the dermis as well as the production of proinflammatory cytokines by both resident epidermal keratinocytes and dermal cells. Tumor necrosis factor-alpha (TNF-alpha) is a proinflammatory cytokine that has been shown to be a major mediator of UVB light effects on cutaneous immunity. Recent studies have demonstrated that pentoxifylline (PTX), a xanthine-derived phosphodiesterase inhibitor, has the ability to inhibit synthesis of TNF-alpha. To examine the effects of PTX on UVB-mediated cutaneous inflammation, Skh/hr hairless mice were injected intraperitoneally with either phosphate-buffered saline or 50 microg/g PTX 1 h before exposure to 2240 J/m2 UVB. Reverse transcription-polymerase chain reaction and immunohistochemical techniques were used to demonstrate that 24 h to 1 wk after UVB-light irradiation, PTX inhibited UVB-induced TNF-alpha gene expression, inhibited the increase in epidermal TNF-alpha protein synthesis, blocked the increase in epidermal proliferation observed after exposure to UVB light, and decreased production of myeloperoxidase by neutrophils infiltrating into the dermis. These studies demonstrated that PTX modifies epidermal responses after acute UVB light exposure and suggest that PTX treatment may be used clinically to modulate the deleterious effects of long-term UVB-light irradiation.


Asunto(s)
Pentoxifilina/farmacología , Traumatismos Experimentales por Radiación/prevención & control , Piel/efectos de la radiación , Rayos Ultravioleta , Animales , Biomarcadores/análisis , División Celular/efectos de los fármacos , División Celular/efectos de la radiación , Inflamación/prevención & control , Ratones , Ratones Pelados , Neutrófilos/efectos de los fármacos , Neutrófilos/fisiología , Neutrófilos/efectos de la radiación , Pentoxifilina/uso terapéutico , Peroxidasa/análisis , Antígeno Nuclear de Célula en Proliferación/análisis , Piel/efectos de los fármacos , Piel/patología , Factor de Necrosis Tumoral alfa/análisis , Factor de Necrosis Tumoral alfa/biosíntesis
9.
Carcinogenesis ; 19(3): 445-55, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9525279

RESUMEN

The beta2 integrin (CD 18/CD 11 a, b, c) family of proteins mediate adherence of leukocytes to vascular endothelium and the associated ligand, intercellular adhesion molecule-1 (ICAM-1; CD 54), interacts with beta2 integrin proteins to allow transendothelial migration of leukocytes into sites of inflammation. The present study examines the function of these proteins in a murine model of acute cutaneous inflammation induced following topical application of 12-O-tetradecanoylphorbol-13-acetate (TPA) to the dorsal epidermis of SENCAR mice and in a model of skin multistage carcinogenesis. At 24 h following topical application of TPA to the dorsal epidermis of mice, dermal leukocytes expressed higher levels of beta2 integrin protein compared with the lower levels of beta2 integrin protein expression by peripheral blood leukocytes. ICAM-1 protein was localized to epidermal keratinocytes and vascular endothelium in TPA-treated skin and to proliferating papilloma cells. Intravenous (i.v.) injection of either 50 microg anti-beta2 integrin antibody alone or in combination with anti-ICAM-1 antibody significantly inhibited both TPA-stimulated neutrophil infiltration into the dermis (P < 0.001) and myeloperoxidase (MPO) activity (P < 0.03 anti-beta2 integrin antibody; P < 0.01 anti-beta2 integrin + ICAM-1 adhesion molecule antibodies), but had no effect on TPA-induced epidermal hyperplasia. In addition, injection of either anti-ICAM-1 adhesion molecule antibody alone (P < 0.004) or in combination with anti-beta2 integrin antibody (P < 0.001) significantly inhibited TPA-induced production of 7,8-dihydroxy-2'-deoxyguanosine (8-OHdG) immunoreactive proteins by epidermal keratinocytes. Beta2 integrin/ICAM-1 adhesion molecules work in concert to regulate migration, retention and functional activation of leukocytes within the dermis during TPA-induced skin inflammation and within stromal tissue of papillomas that form during multi-stage carcinogenesis. Agents that inhibit these receptor/ligand interactions may be useful in defining the roles of specific cell populations in cutaneous inflammation and multistage carcinogenesis and may also have potential as anti-promoting and anti-progression agents.


Asunto(s)
Antígenos CD18/metabolismo , Dermatitis/metabolismo , Molécula 1 de Adhesión Intercelular/metabolismo , Neoplasias Cutáneas/metabolismo , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Antígenos CD18/inmunología , Carcinógenos/toxicidad , División Celular , Dermatitis/patología , Modelos Animales de Enfermedad , Femenino , Inmunohistoquímica , Leucocitos/enzimología , Leucocitos/metabolismo , Ratones , Peroxidasa/biosíntesis , Unión Proteica , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Acetato de Tetradecanoilforbol/toxicidad
10.
Carcinogenesis ; 17(9): 2053-9, 1996 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8824534

RESUMEN

The present studies examined the temporal sequence of inducible nitric oxide synthase (iNOS) gene expression and the cellular sources of iNOS protein and of 3-nitrotyrosine, as a marker of production of nitric oxide-derived reactive nitrogen intermediates during murine multi-stage carcinogenesis. Levels of iNOS mRNA in dorsal skin isolated from acetone-treated female Sencar mice were 2.5-fold higher than iNOS gene expression detected in cutaneous tissue isolated from Sencar mice at 1, 3, 6, 10, 16 and 22 weeks after exposure to a single topical application of 25 nmol 7,12-dimethylbenz[a]anthracene (DMBA) followed by repetitive applications of 2 microgram 17-O-tetradecanoylphorbol-13-acetate (TPA). Papillomas isolated at 16 and 22 weeks of a tumor promotion protocol also had low levels of iNOS mRNA. The diminished levels of iNOS mRNA inversely correlated with the extent of TPA-induced epidermal hyperplasia. In acetone-treated mouse skin, iNOS immunospecific antibody binding was localized to the stratum corneum and suprabasal keratinocytes. In contrast, iNOS protein was present in lower amounts and was localized to the upper-most suprabasal keratinocytes in cutaneous tissue isolated at 22 weeks following a single exposure to either 25 nmol DMBA or acetone and repetitive applications of 2 microgram TPA. At all time points examined over the 22 week time period of papilloma growth, infiltrating neutrophils within the dermis bound significant levels of anti-iNOS antibodies. The production of iNOS by neutrophils within the dermis correlated with the formation of protein nitrotyrosination within the dermal tissue, as detected by 3-nitrotyrosine-specific antibodies. The present studies indicate that NOS and reactive nitrogen intermediates, including peroxynitrite, are produced specifically by dermal neutrophils during the tumor promotion process at time points that correspond to simultaneous production of reactive oxygen intermediates. Conversely, iNOS is simultaneously down-regulated in hyperplastic epidermis and in papillomas.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/toxicidad , Acetona/toxicidad , Carcinógenos/toxicidad , Óxido Nítrico Sintasa/biosíntesis , Neoplasias Cutáneas/patología , Piel/enzimología , Acetato de Tetradecanoilforbol/toxicidad , Transcripción Genética/efectos de los fármacos , Animales , Cartilla de ADN , Inducción Enzimática , Femenino , Queratinocitos/efectos de los fármacos , Queratinocitos/enzimología , Queratinocitos/patología , Ratones , Ratones Endogámicos , Modelos Biológicos , Reacción en Cadena de la Polimerasa , ARN Mensajero/biosíntesis , Piel/efectos de los fármacos , Piel/patología , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/enzimología , Tirosina/análogos & derivados , Tirosina/metabolismo
11.
Carcinogenesis ; 17(8): 1719-28, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8761432

RESUMEN

Topical application of 12-O-tetradecanoylphorbol-13-acetate (TPA) to the dorsal epidermis of Sencar mice induces synthesis of pro-inflammatory cytokines, including interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor-alpha (TNF-alpha). These proteins differentially regulate proliferation of epidermal keratinocytes, as well as stimulate chemotaxis, migration and production of reactive oxygen and nitrogen intermediates by leukocytes. Studies over the past several years have demonstrated that pentoxifylline ([1-(5-oxohexyl)-3,7-dimethyl-xanthine], oxpentifylline), which is a methylxanthine derivative used clinically for treatment of vascular insufficiency, has the unique ability to inhibit synthesis of pro-inflammatory cytokines. The present studies were performed to examine the effects of acute and chronic administration of pentoxifylline on TPA-induced cutaneous inflammation in female Sencar mice treated once with 10 micrograms TPA and also to determine the ability of pentoxifylline to inhibit the tumor promotion process in mice treated with a single application of 25 nmol 7,12-dimethylbenz[a]anthracene (DMBA) followed for 8 weeks by twice weekly topical application of TPA. Intraperitoneal injection of 50 micrograms/g pentoxifylline at 30 min prior to topical application of 10 micrograms TPA to the dorsal epidermis of Sencar mice inhibited TPA-induced IL-1 alpha and TNF-alpha gene expression 24 h after TPA treatment. Administration of pentoxifylline also significantly inhibited all parameters of acute TPA-induced inflammatory response examined 24 h later, including skin thickening (P < 0.005), infiltration of neutrophils into the dermis (P < 0.001), the corresponding dermal myeloperoxidase activity (P < 0.01) and epidermal hyperplasia (P < 0.001). Injection of 50 micrograms/g pentoxifylline over an 8 week time period significantly inhibited DMBA/TPA-induced papilloma growth (P < 0.05). These results indicate that administration of pentoxifylline is an effective means of inhibiting acute TPA-induced cutaneous inflammation and pro-inflammatory cytokine gene expression, as well as is effective as an antipromoter that inhibits papilloma growth.


Asunto(s)
Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Mediadores de Inflamación , Interleucina-1/genética , Papiloma/genética , Pentoxifilina/farmacología , Neoplasias Cutáneas/genética , Factor de Necrosis Tumoral alfa/genética , 9,10-Dimetil-1,2-benzantraceno/antagonistas & inhibidores , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Anticarcinógenos/farmacología , Carcinógenos , División Celular/efectos de los fármacos , Femenino , Ratones , Papiloma/inducido químicamente , Papiloma/patología , Reacción en Cadena de la Polimerasa , Piel/efectos de los fármacos , Piel/patología , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Acetato de Tetradecanoilforbol/antagonistas & inhibidores , Acetato de Tetradecanoilforbol/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA